ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0551

Monogenic Lupus: Clinical Phenotypes and Genetic Mutations in a Cohort of Pediatric Patients

Keerthi Vardhan Yerram1, Kavitha Shanigaaram1, Gaurang Sudhir Deshpande1, Akshay Parikh1, Arjun Ramavath1, Nanditha Gollakota1, Ramesh Manthri1 and Liza Rajasekhar2, 1Department of Clinical Immunology and Rheumatology, Nizams Institute of Medical Sciences, Hyderabad, India, 2Nizam's Institute of Medical Sciences, Madhapur, India

Meeting: ACR Convergence 2023

Keywords: FMF, genetics, lupus-like disease, Systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 12, 2023

Title: (0543–0581) SLE – Diagnosis, Manifestations, & Outcomes Poster I

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Monogenic lupus is associated with specific gene mutations, most commonly reported in TREX1, DNASE1L3, DNASE2, and SAMHD1. However, their phenotypes are not well reported.

Methods: Patients < 16 years of age, satisfying classification criteria for SLE (SLICC 2012) or incomplete lupus1 (ILE)( ANA (titer ≥1:80) and any 1 of acute/ subacute/ chronic cutaneous lupus, oro-nasal ulcers, alopecia, synovitis, serositis, neurologic or renal manifestation or 2 of hematologic, immunologic manifestations, family history of autoimmune rheumatic disease (AIRD) or lupus-like disease(LLD) as per treating physicians opinion, in whom a monogenic cause was suspected due to consanguinity in parents, young age of onset, familial history, recurrent infections, skeletal abnormalities were subjected to clinical exome sequence. Data was retrieved from outpatient and inpatient records. Those with pathogenic variants or with variant of unknown significance but with the same mutation identified in parents were analysed.

Results: Clinical exome revealed mutations in 6 of 7 patients tested (Table 1). The mean age of the patients was 5.3 years( range 2-12) and mean duration of follow-up was 10.8 months (range 4- 21). One patient with a mutation in C1QA gene fulfilled the SLICC-CC (acute cutaneous lupus, oral ulcers, myelitis, lupus nephritis). She also experienced recurrent infections (thigh cellulitis and thumb abscess).

Two patients met the criteria for ILE. One had AIHA, ILD, and low complements and shared a heterozygous mutation in the IFIH1 gene with her mother. The other had oral ulcers, discoid rash, and mutation in C1QB mutation.

Three patients had LLD. One had DAH (diffuse alveolar haemorrhage) and mutation in DNASE1L3 gene, another had urticarial skin rash and low complements with a mutation in CFI gene, and third had AIHA (autoimmune hemolytic anemia), leucopenia, and spondyloenchondroplasia with mutation in ACP5 gene. All, except patient with DNASE1L3 mutation, were ANA positive. None had a family history of AIRD.

Conclusion: We report on 6 patients with mutations in C1QA, C1QB, DNASE1L3, CFI, IFIH1, and ACP5. In 3 with known mutations for monogenic lupus (C1QB, DNASE1L3, ACP5) SLE SLICC criteria were not met. One child presented with DAH. Others had lupus-like autoimmune features and features atypical for ILE eg ILD. Monogenic lupus will allow better research into pathways of disease.

Reference: 1.Lambers WM. Incomplete Systemic Lupus Erythematosus: What Remains After Application of ACR and SLICC criteria? Arthritis Care Res 2020;72(5):607–14.

Supporting image 1

Table 1- Genetic Mutations and Lupus Presentation Categories in Study Patients


Disclosures: K. Yerram: None; K. Shanigaaram: None; G. Deshpande: None; A. Parikh: None; A. Ramavath: None; N. Gollakota: None; R. Manthri: None; L. Rajasekhar: None.

To cite this abstract in AMA style:

Yerram K, Shanigaaram K, Deshpande G, Parikh A, Ramavath A, Gollakota N, Manthri R, Rajasekhar L. Monogenic Lupus: Clinical Phenotypes and Genetic Mutations in a Cohort of Pediatric Patients [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/monogenic-lupus-clinical-phenotypes-and-genetic-mutations-in-a-cohort-of-pediatric-patients/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/monogenic-lupus-clinical-phenotypes-and-genetic-mutations-in-a-cohort-of-pediatric-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology